Paralympic Athletes Clinical Trial
— PARAPERFOfficial title:
Evaluation of Performance in Paralympic Athletes: Performance Outcomes in Sports
The primary objective of the study: improvement of sportive performances by quantification and performances monitoring of paralympic athletes. The secondary objectives of the study: - quantification and performances monitoring of mechanical performances during the filed tests, the laboratory analysis and the sportive competitions; - quantification and performances monitoring of physiological performances during the filed tests, the laboratory analysis and the sportive competitions; - quantification and risk monitoring of discipline-relative musculo-squeletic troubles, caused by training or using of sportive equipment; - quantification and mechanical monitoring by the made-to-measure or usual sportive material.
Status | Recruiting |
Enrollment | 134 |
Est. completion date | June 2024 |
Est. primary completion date | June 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 14 Years and older |
Eligibility | Inclusion Criteria: - High-lever paralympic athletes registered on the ministerial list or selected by Parasport Federation of France or Shooting Federation of France; - Aged >= 14 years; - Informed consent signed by adult athlete or by holder of parental authority or guardian for minor athlete; - Covered by social security system. Exclusion Criteria: - Temporary or definitive contraindication to the practice of the affected sport activity; - Undergoing anti-coagulated treatments; - Cognitive disabilities conducting impossibility to participating to clinical trial, such as serious cognitive troubles, behaviors troubles, psychic troubles or upgraded curatorship needing; - Under guardianship or judicial decision; - Ongoing pregnancy. |
Country | Name | City | State |
---|---|---|---|
France | Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP | Garches |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dynamic sportive activity | Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed. | through study completion, an average of 1 year | |
Primary | Dynamic sportive activity | Dynamic sportive activity: Sprint Capacity Test will be used to have maximal speed. | at 42 months | |
Primary | Static sportive activity | Static sportive activity: maximal speed of movement of pression center. | through study completion, an average of 1 year | |
Primary | Static sportive activity | Static sportive activity: maximal speed of movement of pression center. | at 42 months | |
Secondary | Biomechanical indices of performance: isometric power measurement | Isometric power will be measured by MicroFet & handgrip of 26 measures, advice for healthcare professionals to measure handgrip strength forces to test and document grip deficits and to evaluate consistency of effort. | through study completion, an average of 1 year | |
Secondary | Biomechanical indices of performance: arms and shoulder's Strength | Arms and shoulder's Strength will be measured by force platform. | through study completion, an average of 1 year | |
Secondary | Physiological indices of performance: maximal aerobic speed (MAS) | Maximal aerobic speed (MAS) will be measured by Repetition Per Minute on a Arm ergometer. | Twice through study completion, an average of 42 months | |
Secondary | Physiological indices of performance: maximal aerobic power | Maximal aerobic power will be measured by following Watts fluctuation during the incremental hand-biking test. | Twice through study completion, an average of 42 months | |
Secondary | Fatigue assessment | Fatigue assessment will be measured by Fatigue Index (Power max ratio). | Twice through study completion, an average of 42 months | |
Secondary | Blood lactate concentration | Blood lactatemia level will be measured by lactometer. | immediately after the intervention | |
Secondary | VO2 peak oxygen uptake | VO2 peak oxygen uptake | through study completion, an average of 1 year | |
Secondary | Peak breath expiration volume assessment | VE peak: peak breath expiration volume | through study completion, an average of 1 year | |
Secondary | Peak cardiac frequence | CF: peak cardiac frequence | through study completion, an average of 1 year | |
Secondary | Musculo-squeletic troubles risks measurement | Musculo-squeletic troubles risks will be measured by medical following and clinical method of functional assessment of the shoulder (i.e. "Constant scale"). | through study completion, an average of 1 year | |
Secondary | Time and distance of deceleration of wheelchair during riding test | Time and distance of deceleration of wheelchair during riding test: measured by signal analysis of instrumented wheelchair (inertial control units). | through study completion, an average of 1 year | |
Secondary | Mechanical indices of wheelchair propulsion - applied forces on handrim during the propulsion | Applied forces on handrim during the propulsion: measured by force platform. | through study completion, an average of 1 year | |
Secondary | Acceleration profil during the propulsion | through study completion, an average of 1 year | ||
Secondary | Speed profil during the propulsion | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05916352 -
Effects of Caffeine on Upper Extremity Performance
|
N/A |